Is there any association between antidepressants and restless legs syndrome in a large Turkish population receiving mono or combined treatment? A cross-sectional comparative study

References

• Ekbom KA. Restless legs: a clinical study. Acta Med Scand Suppl. 1945;158:1–123.
   Google Scholar
• Kolla BP, Mansukhani MP, Bostwick JM. The influence of antidepressants on restless legs syndrome and periodic limb movements: a systematic review. Sleep Med Rev. 2018;38:131–140. doi: 10.1016/j.smrv.2017.06.002
   PubMed Web of Science ®Google Scholar
• Koo BB, Blackwell T, Lee HB, et al. Restless legs syndrome and depression: effect mediation by disturbed sleep and periodic limb movements. Am J Geriatr Psychiatry. 2016;24:1105–1116. doi: 10.1016/j.jagp.2016.04.003
   PubMed Web of Science ®Google Scholar
• Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry. 2002;35:109–111. doi: 10.1055/s-2002-31514
   PubMed Web of Science ®Google Scholar
• Leutgeb U, Martus P. Regular intake of non-opioid analgesics is associated with an increased risk of restless legs syndrome in patients maintained on antidepressants. Eur J Med Res. 2002;7:368–378.
   PubMed Web of Science ®Google Scholar
• Allen RP, Lesage S, Earley CJ. Antihistamines, benzodiazapines exacerbate daytime restless legs syndrome (RLS) symptoms. Sleep. 2005;28:279.
   Web of Science ®Google Scholar
• Çalıkuşu C, Küçükgöncü S, Beştepe E. Does antidepressant use increases risk of restless legs syndrome? Arch Neuropsychiatry. 2012;49:212–217. doi: 10.4274/Npa.y6205
   Web of Science ®Google Scholar
• Allen RP, Picchietti DL, Garcia-Borreguero D, et al. International Restless Legs Syndrome Study Group. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance. Sleep Med. 2014;15:860–873. doi: 10.1016/j.sleep.2014.03.025
   PubMed Web of Science ®Google Scholar
• Özbek H, Ağargün MY. Yeni Nesil Antidepresan İlaçlar ve Uyku Üzerine Etkileri. Klinik Psikofarmokoloji Bülteni. 2001;11:272–275.
   Google Scholar
• Rottach KG, Schaner BM, Kirch MH, et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res. 2008 Nov;43(1):70–75. doi: 10.1016/j.jpsychires.2008.02.006
   PubMed Web of Science ®Google Scholar
• Solmaz V, Eser E, Erbaş O. Mirtazapin ve paroksetin kullanımına bağlı gelişen huzursuz bacak sendromu. FNG Bilim Tıp Dergisi. 2016;2(1):60–62.
   Google Scholar
• Fulda S, Kloiber S, Dose T, et al. Mirtazapine provokes periodic leg movements during sleep in young healthy men. Sleep. 2013;36(5):661–669. doi: 10.5665/sleep.2622
   Web of Science ®Google Scholar
• Bahk WM, Pae CU, Chae JH, et al. Mirtazapine may have the propensity for developing a restless legs syndrome? A case report Psychiatry. Clin Neurosci. 2002;56:209–210. doi: 10.1046/j.1440-1819.2002.00955.x
   Google Scholar
• Yang C, White DP, Winkelman JW. Antidepressants and periodic leg movements of sleep. Biol Psychiatry. 2005;58(6):510–514. doi: 10.1016/j.biopsych.2005.04.022
   Web of Science ®Google Scholar
• Bayard M, Bailey B, Acharya D, et al. Bupropion and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med. 2011;24:422–428. doi: 10.3122/jabfm.2011.04.100173
   PubMed Web of Science ®Google Scholar
• Belli H, Akbudak M, Ural C. Duloxetıne-related galactorrhea and restless legs syndrome: a case report. Psychiatr Danub. 2013;25(3):266–267.
   Web of Science ®Google Scholar
• Zhou FM, Liang Y, Salas R, et al. Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron. 2005;46:65–74. doi: 10.1016/j.neuron.2005.02.010
   PubMed Web of Science ®Google Scholar
• Zhou FC, Lesch KP, Murphy DL. Serotonin uptake in to dopamine neurons via dopamine transporters: a compensatory alternative. Brain Res. 2002;942:109–119. doi: 10.1016/S0006-8993(02)02709-9
   Web of Science ®Google Scholar
• Brown LK, Dedrick DL, Doggett JW, et al. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia. Sleep Med. 2005;6:443–450. doi: 10.1016/j.sleep.2005.03.005
   PubMed Web of Science ®Google Scholar
• Lee HB, Hening WA, Allen RP, et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci. 2008;20:101–105. doi: 10.1176/jnp.2008.20.1.101
   PubMed Web of Science ®Google Scholar
• Berkol TD, Alataş E, Doğan Bulu S, et al. Mirtazapine-induced late onset restless leg syndrome, withdrawal symptoms encountered in the process of termination; a case report. Ortadogu Med J. 2015;7(3):158–160.
   Google Scholar
• Nader P, Coralie L, Baleydier B, et al. Restless legs syndrome induced by citalopram: a psychiatric emergency? Gen Hosp Psychiatry. 2007;29(1):72–74. doi: 10.1016/j.genhosppsych.2006.10.006
   Web of Science ®Google Scholar
• Michopoulos I, Ferentinos P, Oulis P, et al. Restless legs syndrome associated with the combined use of quetiapine and venlafaxine. J Clin Psychopharmacol. 2014;34(1):159–161. doi: 10.1097/JCP.0b013e3182a95af2
   Web of Science ®Google Scholar
• Johnson E. Omnibus sleep in American poll. Washington (DC): National Sleep Foundation; 1999.
   Google Scholar
• Yeh P, Walters AS, Tsuang JW. Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath. 2012;16:987–1007. doi: 10.1007/s11325-011-0606-x
   PubMed Web of Science ®Google Scholar
• Thorpy MJ and the Diagnostic Classification Steering Committee. The international classification of sleep disorders: diagnostic and coding manual. Rochester (MN): American Sleep Disorders Association; 1990.
   Google Scholar
• Berger K, Luedemann J, Trenkwalder C, et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164:196–202. doi: 10.1001/archinte.164.2.196
   PubMed Web of Science ®Google Scholar